As of June 26, 2025, AK Medical Holdings Ltd (1789.HK) reports a ROE (Return on Equity) of 10.38%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of AK Medical Holdings Ltd's ROE (Return on Equity)
Over recent years, AK Medical Holdings Ltd's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 10.38% |
| 2023-12-31 | 7.61% |
| 2022-12-31 | 9.13% |
| 2021-12-31 | 4.56% |
| 2020-12-31 | 15.37% |
This slight upward trend highlights how AK Medical Holdings Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing AK Medical Holdings Ltd's ROE (Return on Equity) to Peers
To better understand AK Medical Holdings Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| AK Medical Holdings Ltd (1789.HK) | 10.38% |
| APT Medical Inc (688617.SS) | 26.75% |
| Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) | 26.25% |
| Shenzhen Lifotronic Technology Co Ltd (688389.SS) | 16.84% |
| Double Medical Technology Inc (002901.SZ) | 11.59% |
| iRay Technology Co Ltd (688301.SS) | 10.03% |
Compared to its competitors, AK Medical Holdings Ltd's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.